GCG and Hypoglycemia: Slightly higher glucagon levels during hypoglycemia in the GLP-1 group compared to the control experiments was previously found in studies with the GLP-1 analog exenatide (Degn et al., 2004) and the DPP-IV inhibitor Vildagliptin (Ahren et al., 2009).